Engineering of polymer-surfactant nanoparticles of doxycycline hydrochloride for ocular drug delivery.

scientific article

Engineering of polymer-surfactant nanoparticles of doxycycline hydrochloride for ocular drug delivery. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/10717544.2014.893381
P698PubMed publication ID24601827

P2093author name stringVarsha Pokharkar
Leenata Mandpe
Vikram Patil
P2860cites workTreatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroidsQ28204649
Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye.Q30813799
Production and characterization of a budesonide nanosuspension for pulmonary administrationQ30825039
The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa.Q30988191
Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(epsilon-caprolactone) nanoparticlesQ33477577
Nanocarriers in ocular drug delivery: an update reviewQ33494683
Vesicular systems in ocular drug delivery: an overviewQ35617707
Applications of nanoparticles in ophthalmologyQ37786424
Natural gum reduced/stabilized gold nanoparticles for drug delivery formulationsQ39930020
Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicityQ40548761
Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug deliveryQ43254741
Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticlesQ43459790
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic applicationQ44052992
Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic applicationQ44608209
Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cellsQ45158775
Studies on a new device for drug delivery to the eye.Q45231707
Ocular injuries following sulfur mustard exposure--pathological mechanism and potential therapy.Q46210774
Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.Q46786043
Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activityQ46832593
Polymer-surfactant nanoparticles for sustained release of water-soluble drugsQ50465664
The effect of doxycycline temperature-sensitive hydrogel on inhibiting the corneal neovascularization induced by BFGF in rats.Q51537079
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectnanoparticleQ61231
doxycyclineQ422442
drug deliveryQ1392806
P304page(s)955-968
P577publication date2014-03-06
P1433published inDrug DeliveryQ5308838
P1476titleEngineering of polymer-surfactant nanoparticles of doxycycline hydrochloride for ocular drug delivery.
P478volume22

Reverse relations

cites work (P2860)
Q47590122An alternative choice of lidocaine-loaded liposomes: lidocaine-loaded lipid-polymer hybrid nanoparticles for local anesthetic therapy
Q39386513Approaches in topical ocular drug delivery and developments in the use of contact lenses as drug-delivery devices
Q49996892Ophthalmic Drug Delivery Systems for Antibiotherapy-A Review
Q90214480Smart phase transformation system based on lyotropic liquid crystalline@hard capsules for sustained release of hydrophilic and hydrophobic drugs

Search more.